NYSE:DVA

Davita Healthcare Partners Stock News

etoro logo Buy DVA
*Your capital is at risk
$195.03
+7.14 (+3.80%)
At Close: Jun 03, 2026

Should Value Investors Buy DaVita (DVA) Stock?

10:40am, Thursday, 02'nd Jan 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $155.06, denoting a +1.33% change from the preceding trading day.
Warren Buffett is recognized for his legendary ability to uncover high-quality and undervalued companies to invest in. Under his leadership, Berkshire Hathaway (BRK.B 0.86%) (BRK.A 1.37%) has crushed
Strength in kidney care services and expansion into international markets raise optimism for DVA stock.
Warren Buffett, the longtime head of Berkshire Hathaway (BRK.A 0.99%) (BRK.B 0.95%), has delivered an impressive nearly 20% annualized return for shareholders since 1965, doubling the S&P 500's benchm
Despite operational success and growth potential, I rate DaVita Inc. a “Hold” due to its high debt, lack of dividend, and current overvaluation. DaVita excels in dialysis services but faces signif
More than 8,300 people joined the annual event to raise funds for Bridge of Life DENVER , Nov. 12, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced the success
DENVER , Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will par

Why DaVita Stock Withered on Wednesday

06:38pm, Wednesday, 30'th Oct 2024
The company's profitability is going in the wrong direction for many investors.
This week marks a fire hose of earnings from several top Warren Buffett stock holdings. "Extraordinary business" Apple is on deck Thursday.
DVA's robust Dialysis patient service revenues drives its third-quarter performance.
DaVita Inc. (NYSE:DVA ) Q3 2024 Earnings Conference Call October 29, 2024 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Offi
DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, missing the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.85 per share a year ago.
DaVita reported third-quarter profit that missed Wall Street estimates on Tuesday, hurt by high patient care costs.

DaVita Inc. 3rd Quarter 2024 Results

04:05pm, Tuesday, 29'th Oct 2024
DENVER , Oct. 29, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2024. "We continue to provide quality care for our patient
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE